PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Applied Spectral Imaging, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ASI Announces the Launch of GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis - Applied Spectral Imaging's GenASIs - the automated imaging platforms for genetic and pathology analysis - Spectral-Imaging.com
ASI Announces the Launch of GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis

 

NewswireToday - /newswire/ - Carlsbad, CA, United States, 2011/12/19 - Applied Spectral Imaging's GenASIs - the automated imaging platforms for genetic and pathology analysis - Spectral-Imaging.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Applied Spectral Imaging (ASI) announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.

The GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI’s new offering. With its superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis.

GenASIs enables automated pathology tissue analysis for primary diagnostics, creating reproducible and reliable results. GenASIs can grow with current and future laboratory needs. The GenASIs platforms offer a comprehensive solution ensuring reliability and quality results every time, while allowing cytogeneticists, pathologists and technologists to focus on the clinical rather than the technical components.

ASI’s advanced solutions accommodate the market demand for faster, more powerful imaging and analysis tools catering to the growing need for high throughput solutions empowering laboratories to do more with less.

Limor Shiposh, ASI’s CEO, said: “I am confident that the introduction of our new GenASIs platforms and product suite will allow us to further broaden our market presence and establish ASI as the leader in image acquisition and analysis worldwide for the cytogenetic and pathology markets.” Limor further added that “With quality service being in our genes we will continue to listen to our customers, understand their needs and provide them with superior solutions. Our ongoing success is built on setting new industry standards of quality, reliability and service with our GenASIs offering. We are gratified with the feedback received from customers who have experienced the GenASIs platforms. This feedback has far exceeded our expectations”.

About ASI

Applied Spectral Imaging (ASI) is the maker of the GenASIs automated imaging platforms for genetic and pathology analysis. ASI (spectral-imaging.com) complies with the highest international quality standards including ISO, CE, CMDCAS and 21CFR part 820. GenASIs is FDA cleared for clinical applications such as UroVysion, HER2/neu FISH, CEP XY, Karyotyping and FISH. ASI has been the industry's leading provider of microscopy imaging solutions since 1993. It has over 30 registered patents in the US, Europe, Japan and the rest of the world. With worldwide offices in the US, Europe and Asia, ASI has built a global network of over 50 distributors.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Applied Spectral Imaging, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


ASI Announces the Launch of GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Aviva Katz - Spectral-Imaging.com 
760-929-2840 dror[.]spectral-imaging.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Applied Spectral Imaging, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Applied Spectral Imaging, Inc. / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Rapid Recovery

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)